Transoesophageal Echocardiography - Dysphagia Risk in Acute Stroke- TEDRAS 2 - Follow Up

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The aim of the prospective observational TEDRAS - Follow-up Trial is to investigate the limitations of the initial TEDRAS - Trial in patients with acute Dysphagia is a common consequence from ischemic stroke and it correlates with an increased risk of pulmonary complications such as aspiration pneumonia and an increased mortality risk. TEDRAS-Trial (Transesophageal Echocardiography: Dysphagia Risk in the Acute Phase After Stroke; ClinTrial.gov identifier NCT04302883) was the first randomized and controlled trial to address the question of the extent to which TEE increases dysphagia risk in acute stroke patients. The results of the study confirmed the hypothesis that dysphagia severity worsens after TEE in the intervention group. The aim of the prospective observational TEDRAS - Follow-up Trial is to investigate the limitations of the initial TEDRAS - Trial in patients with acute ischemic stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Acute cerebral infarction detected by cMRI or cCT

• Indication for TEE

• Neurological deficits

• Written informed consent

Locations
Other Locations
Germany
University Hospital Giessen and Marburg
RECRUITING
Giessen
Contact Information
Primary
Samra Hamzic, Dr
samra.hamzic@neuro.med.uni-giessen.de
+4917699807230
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2025-08-31
Participants
Target number of participants: 40
Treatments
Acute ischemic stroke
Patients with acute ischemic stroke and an indication for a transesophageal ecocardiography
Related Therapeutic Areas
Sponsors
Leads: University of Giessen

This content was sourced from clinicaltrials.gov